Sr Scientist, Biomarker at Gilead Sciences

Foster City, California, United States

Gilead Sciences Logo
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, PharmaceuticalsIndustries

Requirements

  • Strong experimental background and experience in hypothesis-driven biological/translational research
  • Demonstrated ability to execute well-designed experiments in immunology and/or oncology
  • Ability to provide scientific leadership and disease biology direction, with a focus on tumor biology integrated with immunology/immuno-oncology
  • Experience creating and executing high-quality integrated discovery and translational plans for early programs at preclinical and clinical stages
  • Strong scientific communication and interaction skills with external collaborators, key opinion leaders, and academic sites
  • Experience analyzing early and late-stage clinical trials with multi-dimensional human data sets (e.g., genomic, epigenetic, gene expression, metabolomics, multiplexed protein detection, or emerging platforms)
  • Ability to work effectively in a dynamic multidisciplinary matrixed team environment
  • Experience leading and supporting biomarker efforts for late-stage or early development programs

Responsibilities

  • Generate and interpret data from translational and clinical studies
  • Design biomarker experiments and provide biomarker expertise to discovery and development project teams
  • Ensure access to state-of-the-art thinking on appropriate biomarker and diagnostic technologies
  • Provide input on clinical protocols and associated documents
  • Participate in meetings with regulatory authorities
  • Direct the implementation of clinically applicable biomarker assays (e.g., pharmacodynamic, predictive, prognostic, and other biomarkers)
  • Oversee biomarker testing and data analysis in collaboration with functional area representatives, diagnostic team, Clinical Development, and Research partners
  • Lead cross-functional teams to achieve biomarker and translational objectives

Skills

Key technologies and capabilities for this role

BiomarkerImmunologyOncologyTumor BiologyImmuno-oncologyTranslational ResearchHypothesis-driven ResearchScientific LeadershipPreclinical StudiesClinical Studies

Questions & Answers

Common questions about this position

What is the employment type for this Senior Scientist role?

The position is full-time.

Is this Senior Scientist position remote or office-based?

This information is not specified in the job description.

What key skills and experience are required for the Senior Scientist, Biomarker role?

The role requires a strong experimental background in hypothesis-driven biological/translational research, experience in immunology and/or oncology, scientific leadership in tumor biology and immuno-oncology, and expertise in analyzing multi-dimensional human data sets from clinical trials including genomic, epigenetic, and gene expression data.

What is the company culture like at Gilead Sciences?

Gilead emphasizes collaboration, determination, and a relentless drive to make a difference, with every employee playing a critical role in scientific innovations; they focus on great leadership, inclusion, development, and empowerment.

What makes a strong candidate for this Senior Scientist position?

Strong candidates have demonstrated scientific leadership, experience creating and executing discovery and translational plans in tumor biology integrated with immunology/immuno-oncology, and the ability to work in multidisciplinary teams while providing biomarker expertise.

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters
1987Year Founded
$15,873.6MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Benefits

Paid family time off and paid parental time off
Generous 401(k) contribution matching
Comprehensive medical plans that cover both physical and mental healthcare
Global Wellbeing Reimbursement
Time Off
Global Volunteer Day
Giving Together Program
Employee Support Programs
Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.
Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.
Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.
Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.
Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.
Investment in digital health technologies enhances Gilead's R&D and patient engagement.
Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI